Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-23-010120
Filing Date
2023-04-13
Accepted
2023-04-13 07:00:46
Documents
3
Period of Report
2023-05-25

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A mbrx20230403_def14a.htm DEF 14A 633564
2 pcard01.jpg GRAPHIC 158017
3 pcard02.jpg GRAPHIC 92374
  Complete submission text file 0001437749-23-010120.txt   979617
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37758 | Film No.: 23817017
SIC: 2834 Pharmaceutical Preparations